SCHEMBL10526975

SCHEMBL10526975

O=C1CCc2c(nc(Br)c3ncccc23)N1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCNB2 O95067 5/20 0.42
▸ CDK1 P06493 5/20 0.42
▸ CCNB1 P14635 5/20 0.42
▸ CCNB3 Q8WWL7 5/20 0.42
▸ CDK5 Q00535 4/20 0.42
▸ CDK5R1 Q15078 4/20 0.42
▸ GSK3B P49841 3/20 0.42
▸ CRBN Q96SW2 8/20 0.37
▸ DDB1 Q16531 7/20 0.37
▸ ABL1 P00519 1/20 0.37
▸ LCK P06239 1/20 0.37
▸ FYN P06241 1/20 0.37
▸ PIM1 P11309 1/20 0.37
▸ CCNA2 P20248 1/20 0.37
▸ CDK2 P24941 1/20 0.37
▸ FLT4 P35916 1/20 0.37
▸ GSK3A P49840 1/20 0.37
▸ CSNK2A1 P68400 1/20 0.37
▸ CCNA1 P78396 1/20 0.37
▸ DYRK1A Q13627 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10527877 0.81 KAT2B (0.37) CCNB2CDK1CCNB1CCNB3CDK5
SCHEMBL10527413 0.81 CCNB2 (0.37) CCNB2CDK1CCNB1CCNB3CDK5
SCHEMBL10527139 0.81 CRBN (0.37) CCNB2CDK1CCNB1CCNB3CDK5
SCHEMBL10919563 0.80 CRBN (0.38) CCNB2CDK1CCNB1CCNB3CDK5
SCHEMBL10526370 0.79 IDO1 (0.39) CCNB2CDK1CCNB1CCNB3CDK5
SCHEMBL10526786 0.79 UTS2R (0.41) PIM1KDM4E
SCHEMBL10526800 0.78 ALDH1A1 (0.37) CCNB2CDK1CCNB1CCNB3CDK5
SCHEMBL10525532 0.78 UTS2R (0.39) CCNB2CDK1CCNB1CCNB3CDK5
SCHEMBL10527105 0.77 TLR8 (0.46) PIM1KDM4E
SCHEMBL10525166 0.74 CCNB2 (0.37) CCNB2CDK1CCNB1CCNB3CDK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4801590-A ANGINA, ANTICANCER, CARDIOVASCULAR DISORDERS, HEADACHES, PSORIASIS, ASTHMA, ANTICOAGULANTS BEIERSDORF AG (DE) 1989-01-31 — — US disclosed
EP-0253171-A1 Pyrido[1,8]naphthyridinones, process for their preparation and their use and compositions containing them Beiersdorf-Lilly GmbH (DE) 1988-01-20 — — EP disclosed
Send feedback